𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C)

✍ Scribed by Doz. Dr. Henning Breithaupt; Hans Pralle; Thomas Eckhardt; Michael Von Hattingberg; Jürgen Schick; Helmut Löffler

Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
714 KB
Volume
50
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High doses of cytosine arabinoside (HD-A
High doses of cytosine arabinoside (HD-Ara-C) as reinforcement during remission of acute myeloid leukemia
✍ Zittoun, R. ;Marie, J. P. ;Pommier, Y. ;Pochat, L. 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 1 views

High doses of Cytosine-arabinoside (Ara-C) (1 to 3gm/mz every 12 hours during 48 hours) were administered monthly to 5 acute myeloid leukemia patinets during complete remissions subsequent to relapses and reinduction treatment. Plasma Ara-C was measured using a radioimmunoassay and exhibited kinetic

High antileukemic activity of sequential
High antileukemic activity of sequential high dose cytosine arabinoside and mitoxantrone in patients with refractory acute leukemias : Results of a clinical Phase II study
✍ Wolfgang Kern; Eberhard Schleyer; Michael Unterhalt; Bernhard Wörmann; Thomas Bü 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

Department of Heremission whereas 5 patients (23%) succumbed to early death and 3 patients (14%) matology and Oncology, Go ¨ttingen, Germany. did not respond. Blood counts recovered at a median of 33.5 days after the start 2 Westfa ¨lische Wilhelms University, Department of treatment and complete r

High-dose cytosine arabinoside in the tr
High-dose cytosine arabinoside in the treatment of refractory acute nonlymphocytic leukemia in adults: Results of two six-day regimens
✍ Herzig, Roger H. ;Herzig, Geoffrey P. ;Lazarus, Hillard M. ;Wolff, Steven N. ;Ph 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 1 views

High-dose cytosine arabinoside (Ara-C) was used in adult patients with refractory acute nonlymphoblastic leukemia, either alone (3 g/m2 every 12 h X 12 doses) or with 3 additional days of anthracycline antibiotics. The systemic toxicities were similar for both groups without an increase in the group